|
FORM
12b-25
|
SEC
FILE NUMBER:
001-34080
|
|||
|
NOTIFICATION
OF LATE FILING
|
CUSIP
NUMBER:
16941P
10 2
|
|
(Check
One):
|
o Form
10-K
|
o Form
20-F
|
o Form
11-K
|
x Form
10-Q
|
o Form
10-D
|
o Form
N-SAR
|
o Form
N-CSR
|
|
For
Period Ended:
|
March
31, 2010
|
|||||||||||||||
|
o
|
Transition
Report on Form 10-K
|
|||
|
o
|
Transition
Report on Form 20-F
|
|||
|
o
|
Transition
Report on Form 11-K
|
|||
|
o
|
Transition
Report on Form 10-Q
|
|||
|
o
|
Transition
Report on Form N-SAR
|
|
For
the Transition Period Ended:
|
|
If
the notification relates to a portion of the filing checked above,
identify the Item(s) to which notification relates:
|
|||
|
PART
I - REGISTRANT INFORMATION
|
|||
|
CHINA
SKY ONE MEDICAL, INC.
|
|||
|
Full
Name of Registrant
|
|||
|
N/A
|
|||
|
Former
Name if Applicable
|
|||
|
No.
2158, North Xiang An Road, Song Bei District
|
|||
|
Address
of Principal Executive Office (Street and
Number):
|
|||
|
Harbin,
Heilongjiang Province, People’s Republic of China, 150028
|
|||
|
City,
State and Zip Code
|
|||
|
PART
II - RULE 12b-25(b) AND (c)
|
|||
|
If
the subject
report could not be filed without unreasonable effort or expense and the
registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate.)
|
|||
|
(a) The
reasons described in reasonable detail in Part III of this form could not
be eliminated without unreasonable effort or expense;
|
|||
|
x
|
(b) The
subject annual report, semi-annual report, transition report on Form 10-K,
10-KSB, 20-F, 11-K, Form N-SAR or Form N-CSR, or portion thereof will be
filed on or before the 15th calendar day following the prescribed due
date; or the subject quarterly report or transition report on Form 10-Q,
or subject distribution report on Form 10-D, or portion thereof, will be
filed on or before the fifth calendar day following the prescribed due
date; and
|
||
|
(c) The
accountant's statement or other exhibit required by Rule 12b-25(c) has
been attached if applicable.
|
|||
|
PART
III - NARRATIVE
|
|
State
below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q,
10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not
be filed within the prescribed time period.
|
|
We
were not able to file our Quarterly Report on Form 10-Q, for the fiscal
quarter ended March 31, 2010, on or prior to May 10, 2010, because we are in the process of
valuing our outstanding warrants to effect the appropriate accounting
treatment under Accounting Standards Codification 815-40, “Derivatives and Hedging –
Contracts in Entity’s Own Equity”, formerly Emerging Issues Task
Force Issue No. 07-05, “Determining Whether an
Instrument (or Embedded Feature) Is Indexed to an Entity’s Own
Stock”. As a result, our financial information could not
be compiled and reviewed internally in a time frame sufficient to permit
our independent auditors to review such information on a timely basis,
without unreasonable effort and expense. We anticipate that the subject report will
be filed on or before
the 5th calendar day
following the prescribed due date.
|
|
PART
IV - OTHER INFORMATION
|
|||||||||
|
(1)
|
Name
and telephone number of person to contact in regard to this
notification
|
||||||
|
Stanley
Hao
|
86-451-87032617
(China)
|
||||||
|
(Name)
|
(Area
Code)
|
(Telephone
Number)
|
|||||
|
(2)
|
Have
all other periodic reports required under Section 13 or 15(d) of the
Securities Exchange Act of 1934 or Section 30 of the Investment
Company Act of 1940 during the preceding 12 months or for such shorter
period that the registrant was required to file such report(s) been
filed? If the answer is no, identify
report(s).
|
||||||
|
Yes x Noo
|
|||||||
|
(3)
|
Is
it anticipated that any significant change in results of operations from
the corresponding period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion
thereof?
|
||||||
|
Yes
x No o
|
|||||||
|
If
so, attach an explanation of the anticipated change, both narratively and
quantitatively, and, if appropriate, state why a reasonable estimate of
the results cannot be made.
See
Attachment
|
|||||||
|
CHINA
SKY ONE MEDICAL, INC.
|
||
|
(Name
of Registrant as Specified in Charter)
|
|
has
caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
|
||||
|
Date:
|
May
10, 2010
|
By:
|
/s/ Liu Yan-qing | |
|
Name:
Liu Yan-qing
|
||||
|
Title:
President and Chief Executive
Officer
|
|
ATTENTION
Intentional misstatements or
omissions of fact constitute Federal Criminal Violations (See
18 U.S.C. 1001).
|
|
|
·
|
revenues
to increase to approximately $28.9 million for the three month period
ended March 31, 2010, from approximately $24.8 million for the three month
period ended March 31, 2009;
|
|
|
·
|
income
from operations to increase to approximately $10.1 million for the three
month period ended March 31, 2010, from approximately $9.1 million in the
comparable period in the previous year;
and
|
|
|
·
|
comprehensive
income for the first quarter of fiscal 2010 to be between $12.1 million
and $13.1 million (including a $4.5 million - $5.5 million gain on change
in fair value of derivatives), compared to approximately $7.4 million for
the three month period ended March 31,
2009.
|